CA
NZ
UK
AU
IND
US
Biotech shares are reacting this week to a rare stacking of catalysts: a large medical meeting, a regulatory reversal and a filing decision, all inside a few trading days. The American Society of Nephrology's Kidney Week runs from October 21 to 25 in Denver …
Bitcoin was trading near $81,500 on Friday, October 23, which is roughly 35.4% below the record of about $126,200 set on October 6, 2025. The gap reflects a year in which the largest cryptocurrency spent much of 2026 in a bear market, then staged …
US spot bitcoin ETFs recorded net outflows of $635.6 million on Thursday, October 22, the day bitcoin dipped below $80,000 for the first time in about a month. It was the largest daily withdrawal since the $484.9 million recorded on October 7, and it …
Booz Allen Hamilton (NYSE:BAH) reports fiscal second-quarter 2027 results on Friday, October 23, with a call at 8:00 a.m. Eastern time. The focus is whether revenue can stabilize after the first quarter, when it fell 4.2% to $2.80 billion even as adjusted EPS rose …
Several companies paired third-quarter results with new repurchase authorizations this week, though not every program is new. General Motors (NYSE:GM) announced a multi-year $20 billion authorization with no expiration date on Tuesday, October 20. It follows a separate $6 billion program announced in January.
Cadence Design Systems (NASDAQ:CDNS) will discuss third-quarter 2026 results in a webcast on Monday, October 26, at 2:00 p.m. Pacific Time, according to a company notice issued on October 5. The report follows a second quarter in which the company beat its own guidance …
Capital returns are the cash companies send back to shareholders through dividends and buybacks, and this week's reports showed both rising and pausing. General Motors (NYSE:GM) announced a $20 billion buyback on October 20, Columbia Banking System (NASDAQ:COLB) approved up to $1.2 billion on …
Biotechs are pivoting because the economics of ex vivo cell therapy, in which a patient's cells are removed, engineered and returned, are hard to sustain on a small balance sheet. In-body, or in vivo, approaches promise to skip the manufacturing step, and several developers …
Because several combine the same ingredients: tiny share counts after serial consolidations and frequent small offerings priced near market lows. On Thursday, October 22, China SXT Pharmaceuticals (NASDAQ:SXTC) traded down 34.52% at $0.0478, Top Wealth Group (NASDAQ:TWG) traded down 28.59% at $0.0482 and Lianhe …
A clinical hold is an order from the FDA to delay a proposed clinical investigation or suspend an ongoing one. It applies to studies under an investigational new drug application, and it can be issued by phone or in writing. The order must identify …
Please wait processing your request...